Maximizing Anticancer Response with MPS1 and CENPE Inhibition Alongside Apoptosis Induction
Antimitotic compounds, targeting key spindle assembly checkpoint (SAC) components (e.g., MPS1, Aurora kinase B, PLK1, KLP1, CENPE), are potential alternatives to microtubule-targeting antimitotic agents (e.g., paclitaxel) to circumvent resistance and side effects associated with their use. They can...
Saved in:
Main Authors: | Bárbara Pinto (Author), João P. N. Silva (Author), Patrícia M. A. Silva (Author), Daniel José Barbosa (Author), Bruno Sarmento (Author), Juliana Carvalho Tavares (Author), Hassan Bousbaa (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and Molecular Features of Anti-CENP-B Autoantibodies
by: Rahul M. Prasad, et al.
Published: (2021) -
Analyzing the expression and clinical significance of CENPE in gastric cancer
by: Jing Wang, et al.
Published: (2024) -
Novel Anticancer Strategies
by: Hassan Bousbaa
Published: (2021) -
Novel Anticancer Strategies II
by: Hassan Bousbaa
Published: (2023) -
Cardiac-specific deletion of the microtubule-binding protein CENP-F causes dilated cardiomyopathy
by: Ellen Dees, et al.
Published: (2012)